期刊文献+

天然黄酮类化合物及其衍生物的构效关系研究进展 被引量:55

Advances in the structure-activity relationship study of natural flavonoids and its derivatives
原文传递
导出
摘要 天然黄酮类化合物是广泛分布于自然界的一大类化合物,已有文献报道其具有抗癌、抗氧化、抗炎、保肝、抗血栓形成、舒张血管、抗病毒、抗菌和抗过敏等多种药理活性。但该类化合物因溶解度差、生物利用度不高等自身缺点而限制了临床上的广泛应用。目前国内外许多课题组选择以天然黄酮为研究对象,通过结构改造研究其针对不同生理活性的构效关系,力求克服其自身缺点,开发出一批具有新颖结构的黄酮类药物的先导化合物。本文总结分析了近几年该类化合物构效关系的研究进展,期望为黄酮类衍生物的设计合成提供参考。 Flavonoids are a large class of compounds widely distributed in nature.Many pharmacological activities of flavonoids have been reported such as anti-cancer,antioxidant,anti-inflammatory,hepatoprotective,antithrombotic,vasodilator,antiviral,antibacterial,antiallergic,and so on.In recent years,domestic and foreign research groups choose natural flavonoids and optimize their chemical structures in order to develop a number of new derivatives with stronger pharmacological activities.As part of the mechanisms are not clear,we need to strengthen in-depth research in the SAR(structure-activity relationship) study for targeted and efficient structure optimization.This paper systematically summarize current researches in the SAR studies of flavonoids and their derivatives,which can serve as a reference for synthesizing new flavonoid derivatives.
出处 《药学学报》 CAS CSCD 北大核心 2011年第6期622-630,共9页 Acta Pharmaceutica Sinica
基金 国家"重大新药创制"科技重大专项资助项目(2009ZX09311)
关键词 黄酮类化合物 衍生物 构效关系 flavonoids derivatives structure-activity relationship
  • 相关文献

参考文献1

二级参考文献24

  • 1Messina M. Soyfoods and soybean phyto-oestrogens (isoflavones) as possible alternatives to hormone replacement therapy(HRT)[J]. European Journal of Cancer, 2000, 36:S71 -S77.
  • 2Ganry O. Phytoestrogen and breast cancer prevention [J]. European Journal of Cancer Prevention, 2002, 11 (6) : 519-522.
  • 3Sarkar F. H. , Li Y. W. Mechanisms of cancer chemoprevention by soy isoflavone genistein [J]. Cancer and Metastasis Reviews, 2002, 21:265~280.
  • 4Dellapenna D. Nutritional genomics: Manipulating plant micronutrients to improve human health [J]. Science, 1999, 285(16):375-79.
  • 5Zaizen Y., Tokuda H., Nishino H., Takeshita M. Inhibitory effect of soybean hypocotyls on Epstein-barr virus early antigen induction and skin tumor promotion [J]. Cancer Letters, 1997, 121:53-57.
  • 6L'homme R. , Brouwers E. , Al-Maharik et al. Time-resolved fluoroimmunoassay of plasma and urine O-desrnethyl-angolensin [J]. Journal of Steroid Biochemistry & Molecular Biology, 2002, 81:353~361.
  • 7Bowey E., Adlercreutz H. , Rowland I. Metabolism of isoflavones and lignans by the gut microflora: a study in germ-free and human flora associated rats [J]. Food and Chemical Toxicology, 2003, 41 (5): 631~636.
  • 8Hur H.G. , Lay Jr. J. O., Beger R.D. et al. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin [J]. Archives of Microbiology, 2000, 174 (6) : 422~428.
  • 9Richelle M. , Priclmore-Merten S., Bodenstab S. et al. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosi-dase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women [J]. Journal of Nutrition, 2002,132 (9): 2587~2592.
  • 10Zubik L. , Meydani M. Bioavailability of soybean isoflavones from aglycone and glueoside forms in American women. American Journal of Clinical Nutrition, 2003, 77 (6) : 1459~ 1465.

共引文献16

同被引文献757

引证文献55

二级引证文献404

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部